Related references
Note: Only part of the references are listed.Cancer drug resistance induced by EMT: novel therapeutic strategies
Javier De las Rivas et al.
ARCHIVES OF TOXICOLOGY (2021)
Mass spectrometry?based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells
Ian M. McDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
Qinyang Xu et al.
EBIOMEDICINE (2020)
Enigmatic MELK: The controversy surrounding its complex role in cancer
Ian M. McDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Alexandre Chlenski et al.
MOLECULAR CANCER THERAPEUTICS (2019)
MELK is a novel therapeutic target in high-risk neuroblastoma
Shan Guan et al.
ONCOTARGET (2018)
MELK expression correlates with tumor mitotic activity but is not required for cancer growth
Christopher J. Giuliano et al.
ELIFE (2018)
A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells
Yubao Wang et al.
ISCIENCE (2018)
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun
X. Xie et al.
ONCOGENE (2017)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies
Mary Kathryn Pitner et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
MELK is not necessary for the proliferation of basal-like breast cancer cells
Hai-Tsang Huang et al.
ELIFE (2017)
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
Ann Lin et al.
ELIFE (2017)
Soft Agar Colony Formation Assay as a Hallmark of Carcinogenesis
Feng Du et al.
BIO-PROTOCOL (2017)
Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth
Ramakrishna Edupuganti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence
Hongping Xia et al.
CANCER LETTERS (2016)
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer
Corey Speers et al.
CLINICAL CANCER RESEARCH (2016)
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
Suyoun Chung et al.
Oncotarget (2015)
MELK-a conserved kinase: functions, signaling, cancer, and controversy
Ranjit Ganguly et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor
Yong-Soon Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
Yubao Wang et al.
ELIFE (2014)
Structural Insight into Maternal Embryonic Leucine Zipper Kinase (MELK) Conformation and Inhibition toward Structure-Based Drug Design
Giulia Canevari et al.
BIOCHEMISTRY (2013)
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
Kaushal Joshi et al.
STEM CELLS (2013)
Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells
Magdalena Ksiazkiewicz et al.
PATHOBIOLOGY (2012)
Characteristics of triple-negative breast cancer
Tim C. de Ruijter et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Epithelial-mesenchymal transition in breast cancer progression and metastasis
Yifan Wang et al.
Chinese Journal of Cancer (2011)
PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase
Chandra Bartholomeusz et al.
CLINICAL CANCER RESEARCH (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
Ann H. Klopp et al.
PLOS ONE (2010)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
Mark R. Pickard et al.
BREAST CANCER RESEARCH (2009)
Affymetrix Whole-Transcript Human Gene 1.0 ST array is highly concordant with standard 3′ expression arrays
Sylvain Pradervand et al.
BIOTECHNIQUES (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas
Suely K. N. Marie et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients - A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database
Gloria J. Morris et al.
CANCER (2007)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression pro-filing study
Yun Gong et al.
LANCET ONCOLOGY (2007)
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
Meng-Lay Lin et al.
BREAST CANCER RESEARCH (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
Marija Balic et al.
CLINICAL CANCER RESEARCH (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers
D Gray et al.
CANCER RESEARCH (2005)
A small molecule-kinase interaction map for clinical kinase inhibitors
MA Fabian et al.
NATURE BIOTECHNOLOGY (2005)
Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition
P Savagner
BIOESSAYS (2001)
Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue™
H Gloeckner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Share Paper
